CCLA Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-457,682
Closed -$52.8M 74
2023
Q2
$52.8M Buy
457,682
+8,536
+2% +$969K 0.94% 56
2023
Q1
$47.8M Sell
449,146
-126,618
-22% -$13.7M 0.94% 56
2022
Q4
$63.9M Buy
575,764
+2,577
+0.4% +$263K 1.44% 36
2022
Q3
$49.4M Buy
+573,187
New +$51.2M 1.19% 48
2022
Q1
$4.18M Buy
50,947
+14,291
+39% +$1.13M 0.08% 65
2021
Q4
$2.81M Sell
36,656
-219
-0.6% -$17.4K 0.05% 67
2021
Q3
$2.77M Buy
36,875
+4,929
+15% +$375K 0.05% 64
2021
Q2
$2.48K Sell
31,946
-1,533
-5% -$114K 0.03% 67
2021
Q1
$2.46M Sell
33,479
-743,060
-96% -$54.8M 0.05% 64
2020
Q4
$60.1M Buy
776,539
+8,437
+1% +$645K 1.35% 40
2020
Q3
$60.7M Sell
768,102
-23,384
-3% -$1.83M 1.65% 31
2020
Q2
$58.4M Buy
+791,486
New +$59.6M 1.82% 26

Other funds holding MRK

CCLA Investment Management's MRK Position: Q3 2023 in Review

CCLA Investment Management sold out of Merck (MRK) in Q3 2023, closing a stake of 457,682 shares — an estimated $52.8M sold.

CCLA Investment Management first reported a position in MRK in Q2 2020 and held it in 12 quarters. The position peaked at $63.9M in Q4 2022. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • CCLA Investment Management reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • CCLA Investment Management sold 457,682 Merck shares in Q3 2023, an estimated $52.8M.
  • CCLA Investment Management first reported a position in Merck in Q2 2020 and held it in 12 quarters.
  • CCLA Investment Management's Merck position peaked at $63.9M in Q4 2022.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on CCLA Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.